Trial of the Week: CRASH-3

Highlighting PharmD speakers as they discuss pearls from their upcoming talks at the NSU Critical Care Symposium. NSU Critical Care Symposium Registration Link: https://pharmacy.nova.edu/ce/programs/critical-care-symposium.html Conference overview with Co-Chairs Karen Berger, Pha ...  Show more

Special Guest: Kristen Sherlin, PharmD, BCEMP Pharmacist author on the RSI trial joins to give a behind-the-scenes look at completing a large RCT and so much more. @PharmacyToDose PharmacyToDose@Gmail.com Learn more about your ad choices. Visit megaphone.fm/adchoices 

Join Patrick Georgoff as he welcomes Dr. Gene Moore and Dr. Ian Roberts, two giants in trauma surgery and epidemiology, to discuss tranexamic acid (TXA) in trauma care. Dr. Moore, a legendary trauma surgeon and researcher, and Dr. Roberts, the architect of the CRASH trials, break ...  Show more

Dr. Seemant Chaturvedi discusses two trials in the field of intracerebral hemorrhage: INTERACT-3 trial and the ENRICH trial. This podcast is sponsored by argenx. Visit www.vyvgarthcp.com for more information.   

Contributor: Nick Hatch, MD

Educational Pearls:

We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ...